vs
Enhabit, Inc.（EHAB）とRevolve Group, Inc.（RVLV）の財務データ比較。上の社名をクリックして会社を切り替えられます
Revolve Group, Inc.の直近四半期売上が大きい（$324.4M vs $270.4M、Enhabit, Inc.の約1.2倍）。Revolve Group, Inc.の純利益率が高く（5.7% vs -14.3%、差は20.0%）。Revolve Group, Inc.の前年同期比売上増加率が高い（10.4% vs 4.7%）。Enhabit, Inc.の直近四半期フリーキャッシュフローが多い（$3.3M vs $-13.3M）。過去8四半期でRevolve Group, Inc.の売上複合成長率が高い（9.5% vs 1.5%）
Enhabit, Inc.はアメリカ合衆国テキサス州ダラスに本拠を置く在宅医療・終末期ケアサービスプロバイダーです。現在34州に255箇所の在宅医療拠点と110箇所の終末期ケア拠点を展開し、テキサス、アラバマ、フロリダ、ジョージアなどで事業を集中しています。米国で4番目に大きい在宅医療事業者であり、終末期ケア分野でも有数の事業者で、2022年にEncompass Healthから同事業がスピンオフして設立されました。
Revolve Theatre Companyはテムズ河畔ヘンリーを拠点とする劇団で、政治的なテーマの作品やシェイクスピア劇を専門に制作・上演しており、オリバー・デンチ、ジョー・モリス、トム・スミスの3人が所有しています。
EHAB vs RVLV — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $270.4M | $324.4M |
| 純利益 | $-38.7M | $18.6M |
| 粗利率 | — | 53.3% |
| 営業利益率 | -12.3% | 6.3% |
| 純利益率 | -14.3% | 5.7% |
| 売上前年比 | 4.7% | 10.4% |
| 純利益前年比 | 15.9% | 50.4% |
| EPS（希薄化後） | $-0.76 | $0.27 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $270.4M | $324.4M | ||
| Q3 25 | $263.6M | $295.6M | ||
| Q2 25 | $266.1M | $309.0M | ||
| Q1 25 | $259.9M | $296.7M | ||
| Q4 24 | $258.2M | $293.7M | ||
| Q3 24 | $253.6M | $283.1M | ||
| Q2 24 | $260.6M | $282.5M | ||
| Q1 24 | $262.4M | $270.6M |
| Q4 25 | $-38.7M | $18.6M | ||
| Q3 25 | $11.1M | $21.2M | ||
| Q2 25 | $5.2M | $10.2M | ||
| Q1 25 | $17.8M | $11.8M | ||
| Q4 24 | $-46.0M | $12.3M | ||
| Q3 24 | $-110.2M | $11.0M | ||
| Q2 24 | $-200.0K | $15.4M | ||
| Q1 24 | $200.0K | $10.9M |
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 54.6% | ||
| Q2 25 | — | 54.1% | ||
| Q1 25 | — | 52.0% | ||
| Q4 24 | — | 52.5% | ||
| Q3 24 | — | 51.2% | ||
| Q2 24 | — | 54.0% | ||
| Q1 24 | — | 52.3% |
| Q4 25 | -12.3% | 6.3% | ||
| Q3 25 | 6.4% | 7.1% | ||
| Q2 25 | 6.3% | 5.8% | ||
| Q1 25 | 6.1% | 5.0% | ||
| Q4 24 | -16.0% | 3.9% | ||
| Q3 24 | -38.6% | 5.0% | ||
| Q2 24 | 4.3% | 5.8% | ||
| Q1 24 | 4.9% | 3.4% |
| Q4 25 | -14.3% | 5.7% | ||
| Q3 25 | 4.2% | 7.2% | ||
| Q2 25 | 2.0% | 3.3% | ||
| Q1 25 | 6.8% | 4.0% | ||
| Q4 24 | -17.8% | 4.2% | ||
| Q3 24 | -43.5% | 3.9% | ||
| Q2 24 | -0.1% | 5.4% | ||
| Q1 24 | 0.1% | 4.0% |
| Q4 25 | $-0.76 | $0.27 | ||
| Q3 25 | $0.22 | $0.29 | ||
| Q2 25 | $0.10 | $0.14 | ||
| Q1 25 | $0.35 | $0.16 | ||
| Q4 24 | $-0.92 | $0.18 | ||
| Q3 24 | $-2.20 | $0.15 | ||
| Q2 24 | $0.00 | $0.21 | ||
| Q1 24 | $0.01 | $0.15 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $43.6M | $292.3M |
| 総負債低いほど良い | $426.0M | — |
| 株主資本純資産 | $534.0M | $512.5M |
| 総資産 | $1.2B | $765.0M |
| 負債/資本比率低いほどレバレッジが低い | 0.80× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $43.6M | $292.3M | ||
| Q3 25 | $56.9M | $315.4M | ||
| Q2 25 | $37.1M | $310.7M | ||
| Q1 25 | $39.5M | $300.8M | ||
| Q4 24 | $28.4M | $256.6M | ||
| Q3 24 | $45.7M | $252.8M | ||
| Q2 24 | $28.5M | $244.7M | ||
| Q1 24 | $36.5M | $273.4M |
| Q4 25 | $426.0M | — | ||
| Q3 25 | $441.5M | — | ||
| Q2 25 | $456.9M | — | ||
| Q1 25 | $467.3M | — | ||
| Q4 24 | $492.6M | — | ||
| Q3 24 | $502.9M | — | ||
| Q2 24 | $512.7M | — | ||
| Q1 24 | $526.7M | — |
| Q4 25 | $534.0M | $512.5M | ||
| Q3 25 | $566.8M | $490.2M | ||
| Q2 25 | $552.4M | $468.6M | ||
| Q1 25 | $543.2M | $453.4M | ||
| Q4 24 | $523.5M | $437.8M | ||
| Q3 24 | $566.1M | $420.8M | ||
| Q2 24 | $674.3M | $405.8M | ||
| Q1 24 | $672.3M | $389.9M |
| Q4 25 | $1.2B | $765.0M | ||
| Q3 25 | $1.2B | $751.3M | ||
| Q2 25 | $1.2B | $722.9M | ||
| Q1 25 | $1.2B | $713.9M | ||
| Q4 24 | $1.2B | $665.5M | ||
| Q3 24 | $1.3B | $670.9M | ||
| Q2 24 | $1.4B | $657.8M | ||
| Q1 24 | $1.4B | $650.0M |
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.83× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 0.89× | — | ||
| Q2 24 | 0.76× | — | ||
| Q1 24 | 0.78× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $4.4M | $-10.2M |
| フリーキャッシュフロー営業CF - 設備投資 | $3.3M | $-13.3M |
| FCFマージンFCF / 売上 | 1.2% | -4.1% |
| 設備投資強度設備投資 / 売上 | 0.4% | 1.0% |
| キャッシュ転換率営業CF / 純利益 | — | -0.55× |
| 直近12ヶ月FCF直近4四半期 | $65.8M | $48.0M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $4.4M | $-10.2M | ||
| Q3 25 | $37.8M | $11.8M | ||
| Q2 25 | $10.6M | $12.6M | ||
| Q1 25 | $17.9M | $45.1M | ||
| Q4 24 | $-4.1M | $3.9M | ||
| Q3 24 | $28.4M | $9.1M | ||
| Q2 24 | $9.6M | $-24.7M | ||
| Q1 24 | $17.3M | $38.4M |
| Q4 25 | $3.3M | $-13.3M | ||
| Q3 25 | $36.2M | $7.5M | ||
| Q2 25 | $8.7M | $10.4M | ||
| Q1 25 | $17.6M | $43.4M | ||
| Q4 24 | $-4.7M | $2.1M | ||
| Q3 24 | $27.7M | $8.0M | ||
| Q2 24 | $8.9M | $-25.7M | ||
| Q1 24 | $15.5M | $36.7M |
| Q4 25 | 1.2% | -4.1% | ||
| Q3 25 | 13.7% | 2.5% | ||
| Q2 25 | 3.3% | 3.4% | ||
| Q1 25 | 6.8% | 14.6% | ||
| Q4 24 | -1.8% | 0.7% | ||
| Q3 24 | 10.9% | 2.8% | ||
| Q2 24 | 3.4% | -9.1% | ||
| Q1 24 | 5.9% | 13.5% |
| Q4 25 | 0.4% | 1.0% | ||
| Q3 25 | 0.6% | 1.5% | ||
| Q2 25 | 0.7% | 0.7% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.2% | 0.6% | ||
| Q3 24 | 0.3% | 0.4% | ||
| Q2 24 | 0.3% | 0.4% | ||
| Q1 24 | 0.7% | 0.6% |
| Q4 25 | — | -0.55× | ||
| Q3 25 | 3.41× | 0.56× | ||
| Q2 25 | 2.04× | 1.24× | ||
| Q1 25 | 1.01× | 3.82× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | -1.60× | ||
| Q1 24 | 86.50× | 3.53× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
